AJP - Heart Information on EB 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 287: H1303-H1311, 2004; doi:10.1152/ajpheart.00053.2004
0363-6135/04 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (24)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Engel, D.
Right arrow Articles by Mann, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Engel, D.
Right arrow Articles by Mann, D. L.

Cardiac myocyte apoptosis provokes adverse cardiac remodeling in transgenic mice with targeted TNF overexpression

David Engel,1 Ronald Peshock,2 Robert C. Armstong,3 Natarajan Sivasubramanian,1 and Douglas L. Mann1

1Winters Center for Heart Failure Research, Baylor College of Medicine, and Michael E. DeBakey Veterans Affairs Medical Center, Houston, 77030; 2Department of Radiology, University of Texas Southwestern Medical Center at Dallas, Texas 75235; and 3Idun Pharmaceuticals, San Diego, California 92121

Submitted 5 February 2004 ; accepted in final form 5 April 2004

Although cardiac myocyte apoptosis has been detected in explanted hearts from patients with end-stage dilated and ischemic cardiomyopathy, the relative contribution of apoptotic cell death to left ventricular (LV) remodeling and cardiac decompensation is not known. To determine whether progressive cardiac myocyte apoptosis contributes to the transition from a hypertrophic to a dilated cardiac phenotype that is observed in transgenic myosin heavy chain secreted TNF (MHCsTNF) mice with cardiac restricted overexpression of tumor necrosis factor (TNF), we assessed cardiac myocyte apoptosis (using a DNA ligase technique) in MHCsTNF mice and littermate control mice in relation to serial changes in LV structure, which was assessed using MRI. The prevalence of cardiac myocyte apoptosis increased progressively from 4 to 12 wk as the hearts of the MHCsTNF mice underwent the transition from a concentric hypertrophic to a dilated cardiac phenotype. Treatment of the MHCsTNF mice with the broad-based caspase inhibitor N-[(1,3-dimethylindole-2-carbonyl)-valinyl]-3-amino4-oxo-5-fluoropentanoic acid significantly decreased cardiac myocyte apoptosis and significantly attenuated LV wall thinning and adverse cardiac remodeling. Additional studies suggested that the TNF-induced decrease in Bcl-2 expression and activation of the intrinsic mitochondrial death pathway were responsible for the cardiac myocyte apoptosis observed in the MHCsTNF mice. These studies show that progressive cardiac myocyte apoptosis is sufficient to contribute to adverse cardiac remodeling in the adult mammalian heart through progressive LV wall thinning.

tumor necrosis factor; cell death; caspase; congestive heart failure; magnetic resonance imaging



Address for reprint requests and other correspondence: D. L. Mann, Winters Center for Heart Failure Research, 6565 Fannin St., MS 524, Houston, TX 77030 (E-mail: dmann{at}bcm.tmc.edu).




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
G. Kewalramani, P. Puthanveetil, F. Wang, M. S. Kim, S. Deppe, A. Abrahani, D. S. Luciani, J. D. Johnson, and B. Rodrigues
AMP-activated protein kinase confers protection against TNF-{alpha}-induced cardiac cell death
Cardiovasc Res, October 1, 2009; 84(1): 42 - 53.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
P. Panagopoulou, C. H. Davos, D. J. Milner, E. Varela, J. Cameron, D. L. Mann, and Y. Capetanaki
Desmin mediates TNF-{alpha}-induced aggregate formation and intercalated disk reorganization in heart failure
J. Cell Biol., October 20, 2008; 181(5): 761 - 775.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Li, X. Jiao, L. Tao, H. Liu, Y. Cao, B. L. Lopez, T. A. Christopher, and X. L. Ma
Tumor necrosis factor-{alpha} in mechanic trauma plasma mediates cardiomyocyte apoptosis
Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1847 - H1852.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. Sekiguchi, Q. Tian, M. Ishiyama, J. Burchfield, F. Gao, D. L. Mann, and P. M. Barger
Inhibition of PPAR-{alpha} activity in mice with cardiac-restricted expression of tumor necrosis factor: potential role of TGF-beta/Smad3
Am J Physiol Heart Circ Physiol, March 1, 2007; 292(3): H1443 - H1451.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
S. Y. Cheranov and J. H. Jaggar
TNF-{alpha} dilates cerebral arteries via NAD(P)H oxidase-dependent Ca2+ spark activation
Am J Physiol Cell Physiol, April 1, 2006; 290(4): C964 - C971.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
C. A. Petersen, K. A. Krumholz, J. Carmen, A. P. Sinai, and B. A. Burleigh
Trypanosoma cruzi Infection and Nuclear Factor Kappa B Activation Prevent Apoptosis in Cardiac Cells
Infect. Immun., March 1, 2006; 74(3): 1580 - 1587.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. Zhang, X. Xu, B. J. Potter, W. Wang, L. Kuo, L. Michael, G. J. Bagby, and W. M. Chilian
TNF-{alpha} Contributes to Endothelial Dysfunction in Ischemia/Reperfusion Injury
Arterioscler Thromb Vasc Biol, March 1, 2006; 26(3): 475 - 480.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J.-F. Wang, A. Meissner, S. Malek, Y. Chen, Q. Ke, J. Zhang, V. Chu, T. G. Hampton, C. S. Crumpacker, W. H. Abelmann, et al.
Propranolol ameliorates and epinephrine exacerbates progression of acute and chronic viral myocarditis
Am J Physiol Heart Circ Physiol, October 1, 2005; 289(4): H1577 - H1583.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
Z. Kassiri, G. Y. Oudit, O. Sanchez, F. Dawood, F. F. Mohammed, R. K. Nuttall, D. R. Edwards, P. P. Liu, P. H. Backx, and R. Khokha
Combination of Tumor Necrosis Factor-{alpha} Ablation and Matrix Metalloproteinase Inhibition Prevents Heart Failure After Pressure Overload in Tissue Inhibitor of Metalloproteinase-3 Knock-Out Mice
Circ. Res., August 19, 2005; 97(4): 380 - 390.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.